CS200455B2 - Method of producing derivatives of benzoxazole - Google Patents
Method of producing derivatives of benzoxazole Download PDFInfo
- Publication number
- CS200455B2 CS200455B2 CS733508A CS350873A CS200455B2 CS 200455 B2 CS200455 B2 CS 200455B2 CS 733508 A CS733508 A CS 733508A CS 350873 A CS350873 A CS 350873A CS 200455 B2 CS200455 B2 CS 200455B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- acid
- group
- propionic acid
- benzoxazolyl
- hydroxyphenyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 12
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical class C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 title claims description 6
- -1 hydroxy, amino Chemical group 0.000 claims abstract description 55
- 150000001875 compounds Chemical class 0.000 claims abstract description 29
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 15
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 7
- 150000002825 nitriles Chemical class 0.000 claims abstract description 5
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims abstract description 4
- 125000005843 halogen group Chemical group 0.000 claims abstract description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 4
- 125000000355 1,3-benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims abstract description 3
- 125000003545 alkoxy group Chemical group 0.000 claims abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 63
- 229910052783 alkali metal Inorganic materials 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- 150000003863 ammonium salts Chemical class 0.000 claims description 4
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000005907 alkyl ester group Chemical group 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims 1
- 150000001342 alkaline earth metals Chemical class 0.000 claims 1
- 125000001188 haloalkyl group Chemical group 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 239000002253 acid Substances 0.000 abstract description 43
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract description 40
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 36
- 150000002148 esters Chemical class 0.000 abstract description 8
- BUJKJUXMIZZWJH-UHFFFAOYSA-N ethyl 2-(2-phenyl-1,3-benzoxazol-6-yl)propanoate Chemical compound O1C2=CC(C(C)C(=O)OCC)=CC=C2N=C1C1=CC=CC=C1 BUJKJUXMIZZWJH-UHFFFAOYSA-N 0.000 abstract description 7
- 150000003839 salts Chemical class 0.000 abstract description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 abstract description 6
- PHTPBESCCSTRDQ-UHFFFAOYSA-N 6-(bromomethyl)-2-phenyl-1,3-benzoxazole Chemical compound O1C2=CC(CBr)=CC=C2N=C1C1=CC=CC=C1 PHTPBESCCSTRDQ-UHFFFAOYSA-N 0.000 abstract description 4
- HNTGXYVCUNUJGL-UHFFFAOYSA-N 6-methyl-2-phenyl-1,3-benzoxazole Chemical compound O1C2=CC(C)=CC=C2N=C1C1=CC=CC=C1 HNTGXYVCUNUJGL-UHFFFAOYSA-N 0.000 abstract description 4
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 abstract description 4
- DMJBUAAUSMMJFJ-UHFFFAOYSA-N ethyl 2-(4-amino-3-hydroxyphenyl)propanoate Chemical compound CCOC(=O)C(C)C1=CC=C(N)C(O)=C1 DMJBUAAUSMMJFJ-UHFFFAOYSA-N 0.000 abstract description 4
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 abstract description 4
- 229910000041 hydrogen chloride Inorganic materials 0.000 abstract description 4
- LZYBWGQSJULAEZ-UHFFFAOYSA-N 2-(4-amino-3-hydroxyphenyl)propanoic acid hydrochloride Chemical compound Cl.OC(=O)C(C)C1=CC=C(N)C(O)=C1 LZYBWGQSJULAEZ-UHFFFAOYSA-N 0.000 abstract description 3
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- BTNSSVRIZUUYGM-UHFFFAOYSA-N 2-(4-hydroxyphenyl)propanenitrile Chemical compound N#CC(C)C1=CC=C(O)C=C1 BTNSSVRIZUUYGM-UHFFFAOYSA-N 0.000 abstract description 2
- HCPJEHJGFKWRFM-UHFFFAOYSA-N 2-amino-5-methylphenol Chemical compound CC1=CC=C(N)C(O)=C1 HCPJEHJGFKWRFM-UHFFFAOYSA-N 0.000 abstract description 2
- NEAQRZUHTPSBBM-UHFFFAOYSA-N 2-hydroxy-3,3-dimethyl-7-nitro-4h-isoquinolin-1-one Chemical compound C1=C([N+]([O-])=O)C=C2C(=O)N(O)C(C)(C)CC2=C1 NEAQRZUHTPSBBM-UHFFFAOYSA-N 0.000 abstract description 2
- 239000004342 Benzoyl peroxide Substances 0.000 abstract description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 abstract description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 abstract description 2
- 238000009835 boiling Methods 0.000 abstract description 2
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract description 2
- 238000007363 ring formation reaction Methods 0.000 abstract description 2
- 150000000183 1,3-benzoxazoles Chemical class 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 abstract 1
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 abstract 1
- 125000004755 (C2-C7) acylamino group Chemical group 0.000 abstract 1
- UFTUPBWIOQDUTI-UHFFFAOYSA-N 2-(3-benzamido-4-hydroxyphenyl)propanoic acid Chemical compound OC(=O)C(C)C1=CC=C(O)C(NC(=O)C=2C=CC=CC=2)=C1 UFTUPBWIOQDUTI-UHFFFAOYSA-N 0.000 abstract 1
- RZSVLKAIDMAXLB-UHFFFAOYSA-N 2-(4-aminophenyl)propanenitrile Chemical compound N#CC(C)C1=CC=C(N)C=C1 RZSVLKAIDMAXLB-UHFFFAOYSA-N 0.000 abstract 1
- YLOVYLOYLHRGAG-UHFFFAOYSA-N 2-(4-hydroxy-3-nitrophenyl)propanenitrile Chemical compound N#CC(C)C1=CC=C(O)C([N+]([O-])=O)=C1 YLOVYLOYLHRGAG-UHFFFAOYSA-N 0.000 abstract 1
- MCHCNXYRQZROHI-UHFFFAOYSA-N 2-[3-[(2-chlorobenzoyl)amino]-4-hydroxyphenyl]propanoic acid Chemical compound OC(=O)C(C)C1=CC=C(O)C(NC(=O)C=2C(=CC=CC=2)Cl)=C1 MCHCNXYRQZROHI-UHFFFAOYSA-N 0.000 abstract 1
- CVXCGRGLUOUZIE-UHFFFAOYSA-N 2-[3-[(4-chlorobenzoyl)amino]-4-hydroxyphenyl]propanoic acid Chemical compound OC(=O)C(C)C1=CC=C(O)C(NC(=O)C=2C=CC(Cl)=CC=2)=C1 CVXCGRGLUOUZIE-UHFFFAOYSA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical class [H]OC([H])([H])* 0.000 abstract 1
- RRMMMLKTSSCJNL-UHFFFAOYSA-N n-[5-(1-cyanoethyl)-2-hydroxyphenyl]benzamide Chemical compound N#CC(C)C1=CC=C(O)C(NC(=O)C=2C=CC=CC=2)=C1 RRMMMLKTSSCJNL-UHFFFAOYSA-N 0.000 abstract 1
- 230000000802 nitrating effect Effects 0.000 abstract 1
- 125000002560 nitrile group Chemical group 0.000 abstract 1
- 239000001117 sulphuric acid Substances 0.000 abstract 1
- 235000011149 sulphuric acid Nutrition 0.000 abstract 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Substances CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 67
- 239000000243 solution Substances 0.000 description 63
- 229910052799 carbon Inorganic materials 0.000 description 58
- 229910052757 nitrogen Inorganic materials 0.000 description 53
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 32
- 235000019260 propionic acid Nutrition 0.000 description 30
- 238000004458 analytical method Methods 0.000 description 29
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 27
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 26
- BDERNNFJNOPAEC-UHFFFAOYSA-N n-propyl alcohol Natural products CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 23
- 235000019441 ethanol Nutrition 0.000 description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 20
- 239000000203 mixture Substances 0.000 description 19
- 239000003814 drug Substances 0.000 description 17
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- YDGAYOGFRQLWOH-UHFFFAOYSA-N 2-(1,3-benzoxazol-6-yl)acetic acid Chemical compound OC(=O)CC1=CC=C2N=COC2=C1 YDGAYOGFRQLWOH-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 239000000725 suspension Substances 0.000 description 12
- 125000001309 chloro group Chemical group Cl* 0.000 description 11
- 229960004756 ethanol Drugs 0.000 description 11
- 239000004480 active ingredient Substances 0.000 description 9
- 239000013078 crystal Substances 0.000 description 8
- 239000011734 sodium Substances 0.000 description 7
- WITADPXDGQIEMJ-UHFFFAOYSA-N 2-(1,3-benzoxazol-6-yl)acetamide Chemical compound NC(=O)CC1=CC=C2N=COC2=C1 WITADPXDGQIEMJ-UHFFFAOYSA-N 0.000 description 6
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 6
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 5
- 229960000583 acetic acid Drugs 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 5
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 5
- 229940080818 propionamide Drugs 0.000 description 5
- WZZFSFRRNAKILX-UHFFFAOYSA-N 2-(2-phenyl-1,3-benzoxazol-6-yl)acetic acid Chemical compound O1C2=CC(CC(=O)O)=CC=C2N=C1C1=CC=CC=C1 WZZFSFRRNAKILX-UHFFFAOYSA-N 0.000 description 4
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 description 4
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 description 4
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 4
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 150000001340 alkali metals Chemical class 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 125000004432 carbon atom Chemical group C* 0.000 description 4
- 239000012259 ether extract Substances 0.000 description 4
- 125000004494 ethyl ester group Chemical group 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 239000000829 suppository Substances 0.000 description 4
- NGFBZTMAKWKGLF-UHFFFAOYSA-N 2-(1,3-benzoxazol-2-yl)propanoic acid Chemical compound C1=CC=C2OC(C(C(O)=O)C)=NC2=C1 NGFBZTMAKWKGLF-UHFFFAOYSA-N 0.000 description 3
- GEJDTYYMHJURCY-UHFFFAOYSA-N 2-(2-phenyl-1,3-benzoxazol-6-yl)acetonitrile Chemical compound O1C2=CC(CC#N)=CC=C2N=C1C1=CC=CC=C1 GEJDTYYMHJURCY-UHFFFAOYSA-N 0.000 description 3
- NCWBFAPXFARNEF-UHFFFAOYSA-N 2-[2-(4-chlorophenyl)-1,3-benzoxazol-6-yl]propanoic acid Chemical compound O1C2=CC(C(C(O)=O)C)=CC=C2N=C1C1=CC=C(Cl)C=C1 NCWBFAPXFARNEF-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 239000001856 Ethyl cellulose Substances 0.000 description 3
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- NYRJACZZPCHARO-UHFFFAOYSA-N ethyl 2-(2-phenyl-1,3-benzoxazol-6-yl)acetate Chemical compound O1C2=CC(CC(=O)OCC)=CC=C2N=C1C1=CC=CC=C1 NYRJACZZPCHARO-UHFFFAOYSA-N 0.000 description 3
- JRXUWMOGFBHGOZ-UHFFFAOYSA-N ethyl 2-[2-(4-chlorophenyl)-1,3-benzoxazol-6-yl]propanoate Chemical compound O1C2=CC(C(C)C(=O)OCC)=CC=C2N=C1C1=CC=C(Cl)C=C1 JRXUWMOGFBHGOZ-UHFFFAOYSA-N 0.000 description 3
- 235000019325 ethyl cellulose Nutrition 0.000 description 3
- 229920001249 ethyl cellulose Polymers 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 3
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 description 2
- QFHJRGYAPLZITA-UHFFFAOYSA-N 2-(2-phenyl-1,3-benzoxazol-5-yl)acetic acid Chemical compound N=1C2=CC(CC(=O)O)=CC=C2OC=1C1=CC=CC=C1 QFHJRGYAPLZITA-UHFFFAOYSA-N 0.000 description 2
- KIUPORFCHKEHRJ-UHFFFAOYSA-N 2-(2-phenyl-1,3-benzoxazol-5-yl)propanoic acid Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=CC=C1 KIUPORFCHKEHRJ-UHFFFAOYSA-N 0.000 description 2
- CPJAIYJPNFTBRV-UHFFFAOYSA-N 2-(2-phenyl-1,3-benzoxazol-6-yl)propanoic acid Chemical compound O1C2=CC(C(C(O)=O)C)=CC=C2N=C1C1=CC=CC=C1 CPJAIYJPNFTBRV-UHFFFAOYSA-N 0.000 description 2
- IESVGUSNDICIGM-UHFFFAOYSA-N 2-[2-(3,4-dichlorophenyl)-1,3-benzoxazol-5-yl]propanoic acid Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C(Cl)=C1 IESVGUSNDICIGM-UHFFFAOYSA-N 0.000 description 2
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 description 2
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 description 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 2
- IVAATAQAFOAALG-UHFFFAOYSA-N 2h-cyclopenta[c]pyridine Chemical class C1=CNC=C2C=CC=C21 IVAATAQAFOAALG-UHFFFAOYSA-N 0.000 description 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- VYHQRIMWWIIVLE-UHFFFAOYSA-N N-(1,3-benzoxazol-6-yl)propanamide Chemical compound CCC(=O)Nc1ccc2ncoc2c1 VYHQRIMWWIIVLE-UHFFFAOYSA-N 0.000 description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 229940046892 lead acetate Drugs 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 229910017604 nitric acid Inorganic materials 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Chemical compound O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- DKSZLDSPXIWGFO-BLOJGBSASA-N (4r,4ar,7s,7ar,12bs)-9-methoxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-7-ol;phosphoric acid;hydrate Chemical compound O.OP(O)(O)=O.OP(O)(O)=O.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC.C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC DKSZLDSPXIWGFO-BLOJGBSASA-N 0.000 description 1
- WMAKXTBAGPCPMU-UHFFFAOYSA-N 2-(2-butyl-1,3-benzoxazol-6-yl)propanoic acid Chemical compound C1=C(C(C)C(O)=O)C=C2OC(CCCC)=NC2=C1 WMAKXTBAGPCPMU-UHFFFAOYSA-N 0.000 description 1
- VWVVHVWQIHSLCP-UHFFFAOYSA-N 2-(2-cyclohexyl-1,3-benzoxazol-5-yl)acetic acid Chemical compound N=1C2=CC(CC(=O)O)=CC=C2OC=1C1CCCCC1 VWVVHVWQIHSLCP-UHFFFAOYSA-N 0.000 description 1
- OFOHAMUPCQAUKH-UHFFFAOYSA-N 2-(2-cyclohexyl-1,3-benzoxazol-5-yl)acetonitrile Chemical compound N=1C2=CC(CC#N)=CC=C2OC=1C1CCCCC1 OFOHAMUPCQAUKH-UHFFFAOYSA-N 0.000 description 1
- MMIJJTZEIZWIIQ-UHFFFAOYSA-N 2-(2-cyclohexyl-1,3-benzoxazol-5-yl)propanoic acid Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1CCCCC1 MMIJJTZEIZWIIQ-UHFFFAOYSA-N 0.000 description 1
- RJPQYRSNQVZBNQ-UHFFFAOYSA-N 2-(2-cyclohexyl-1,3-benzoxazol-6-yl)acetic acid Chemical compound C1(CCCCC1)C=1OC2=C(N1)C=CC(=C2)CC(=O)O RJPQYRSNQVZBNQ-UHFFFAOYSA-N 0.000 description 1
- HFONNHMHOYERHF-UHFFFAOYSA-N 2-(2-methyl-1,3-benzoxazol-6-yl)butanoic acid Chemical compound CCC(C(O)=O)C1=CC=C2N=C(C)OC2=C1 HFONNHMHOYERHF-UHFFFAOYSA-N 0.000 description 1
- ROZRMLVDMACJMT-UHFFFAOYSA-N 2-(2-phenyl-1,3-benzoxazol-5-yl)acetonitrile Chemical compound N=1C2=CC(CC#N)=CC=C2OC=1C1=CC=CC=C1 ROZRMLVDMACJMT-UHFFFAOYSA-N 0.000 description 1
- YFOCIWCOHSRRKX-UHFFFAOYSA-N 2-(2-phenyl-1,3-benzoxazol-5-yl)propanenitrile Chemical compound N=1C2=CC(C(C#N)C)=CC=C2OC=1C1=CC=CC=C1 YFOCIWCOHSRRKX-UHFFFAOYSA-N 0.000 description 1
- JEPWZFHUFGQYMV-UHFFFAOYSA-N 2-(2-pyrazin-2-yl-1,3-benzoxazol-5-yl)propanoic acid Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CN=CC=N1 JEPWZFHUFGQYMV-UHFFFAOYSA-N 0.000 description 1
- AFIGBQKUTYOIJK-UHFFFAOYSA-N 2-(2-pyrazin-2-yl-1,3-benzoxazol-6-yl)acetic acid Chemical compound N1=C(C=NC=C1)C=1OC2=C(N1)C=CC(=C2)CC(=O)O AFIGBQKUTYOIJK-UHFFFAOYSA-N 0.000 description 1
- ZSNYORFPSOPMQY-UHFFFAOYSA-N 2-(2-pyridin-2-yl-1,3-benzoxazol-5-yl)propanoic acid Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=CC=N1 ZSNYORFPSOPMQY-UHFFFAOYSA-N 0.000 description 1
- WGWKMBLGNLYZNM-UHFFFAOYSA-N 2-(2-pyridin-2-yl-1,3-benzoxazol-6-yl)acetonitrile Chemical compound O1C2=CC(CC#N)=CC=C2N=C1C1=CC=CC=N1 WGWKMBLGNLYZNM-UHFFFAOYSA-N 0.000 description 1
- RBGNJXLWHRZTNZ-UHFFFAOYSA-N 2-(2-pyridin-4-yl-1,3-benzoxazol-5-yl)acetic acid Chemical compound N=1C2=CC(CC(=O)O)=CC=C2OC=1C1=CC=NC=C1 RBGNJXLWHRZTNZ-UHFFFAOYSA-N 0.000 description 1
- ZVBINIQZKBXOHX-UHFFFAOYSA-N 2-(4-amino-3-hydroxyphenyl)propanoic acid Chemical compound OC(=O)C(C)C1=CC=C(N)C(O)=C1 ZVBINIQZKBXOHX-UHFFFAOYSA-N 0.000 description 1
- JGOLVGGDNSGQMM-UHFFFAOYSA-N 2-[2-(2-chlorophenyl)-1,3-benzoxazol-6-yl]propanoic acid Chemical compound O1C2=CC(C(C(O)=O)C)=CC=C2N=C1C1=CC=CC=C1Cl JGOLVGGDNSGQMM-UHFFFAOYSA-N 0.000 description 1
- OWPLCPUZKITHTL-UHFFFAOYSA-N 2-[2-(3,4-diethylphenyl)-1,3-benzoxazol-5-yl]propanoic acid Chemical compound C1=C(CC)C(CC)=CC=C1C1=NC2=CC(C(C)C(O)=O)=CC=C2O1 OWPLCPUZKITHTL-UHFFFAOYSA-N 0.000 description 1
- WQDLJCDVQLHYOK-UHFFFAOYSA-N 2-[2-(3,5-dichlorophenyl)-1,3-benzoxazol-5-yl]propanoic acid Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC(Cl)=CC(Cl)=C1 WQDLJCDVQLHYOK-UHFFFAOYSA-N 0.000 description 1
- GEFRPGHOOMZHRC-UHFFFAOYSA-N 2-[2-(3-chlorophenyl)-1,3-benzoxazol-5-yl]propanoic acid Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=CC(Cl)=C1 GEFRPGHOOMZHRC-UHFFFAOYSA-N 0.000 description 1
- QTCJZIPSBZZCOV-UHFFFAOYSA-N 2-[2-(3-ethoxyphenyl)-1,3-benzoxazol-5-yl]-N-hydroxyacetamide Chemical compound C(C)OC=1C=C(C=CC1)C=1OC2=C(N1)C=C(C=C2)CC(=O)NO QTCJZIPSBZZCOV-UHFFFAOYSA-N 0.000 description 1
- QPJRVPQZLARJGF-UHFFFAOYSA-N 2-[2-(3-fluorophenyl)-1,3-benzoxazol-5-yl]propanoic acid Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=CC(F)=C1 QPJRVPQZLARJGF-UHFFFAOYSA-N 0.000 description 1
- RINYHQOSGRLIMH-UHFFFAOYSA-N 2-[2-(4-acetylphenyl)-1,3-benzoxazol-5-yl]propanoic acid Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(C(C)=O)C=C1 RINYHQOSGRLIMH-UHFFFAOYSA-N 0.000 description 1
- QAAYJMFOLATIBK-UHFFFAOYSA-N 2-[2-(4-aminophenyl)-1,3-benzoxazol-6-yl]acetic acid Chemical compound NC1=CC=C(C=C1)C=1OC2=C(N1)C=CC(=C2)CC(=O)O QAAYJMFOLATIBK-UHFFFAOYSA-N 0.000 description 1
- GLOMGORQFPPRCE-UHFFFAOYSA-N 2-[2-(4-bromophenyl)-1,3-benzoxazol-5-yl]propanoic acid Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Br)C=C1 GLOMGORQFPPRCE-UHFFFAOYSA-N 0.000 description 1
- ULVITXBBPWOWQL-UHFFFAOYSA-N 2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]butanenitrile Chemical compound N=1C2=CC(C(C#N)CC)=CC=C2OC=1C1=CC=C(Cl)C=C1 ULVITXBBPWOWQL-UHFFFAOYSA-N 0.000 description 1
- ARPYQKTVRGFPIS-UHFFFAOYSA-N 2-[2-(4-fluorophenyl)-1,3-benzoxazol-5-yl]propanoic acid Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(F)C=C1 ARPYQKTVRGFPIS-UHFFFAOYSA-N 0.000 description 1
- RYPQWXCEFPLTKJ-UHFFFAOYSA-N 2-[2-(4-nitrophenyl)-1,3-benzoxazol-5-yl]acetic acid Chemical compound [N+](=O)([O-])C1=CC=C(C=C1)C=1OC2=C(N1)C=C(C=C2)CC(=O)O RYPQWXCEFPLTKJ-UHFFFAOYSA-N 0.000 description 1
- QOBLCPCVVJJFPM-UHFFFAOYSA-N 2-[2-(furan-2-yl)-1,3-benzoxazol-5-yl]propanenitrile Chemical compound N=1C2=CC(C(C#N)C)=CC=C2OC=1C1=CC=CO1 QOBLCPCVVJJFPM-UHFFFAOYSA-N 0.000 description 1
- FPYUJUBAXZAQNL-UHFFFAOYSA-N 2-chlorobenzaldehyde Chemical compound ClC1=CC=CC=C1C=O FPYUJUBAXZAQNL-UHFFFAOYSA-N 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- OGCCEWUSWOPOFB-UHFFFAOYSA-N 4,4-dimethylcyclohexa-1,5-dien-1-ol Chemical compound CC1(C)CC=C(O)C=C1 OGCCEWUSWOPOFB-UHFFFAOYSA-N 0.000 description 1
- RKIDDEGICSMIJA-UHFFFAOYSA-N 4-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(Cl)C=C1 RKIDDEGICSMIJA-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- JCLFHZLOKITRCE-UHFFFAOYSA-N 4-pentoxyphenol Chemical compound CCCCCOC1=CC=C(O)C=C1 JCLFHZLOKITRCE-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WPUNYGUYZBSAKA-UHFFFAOYSA-N C(C)(C)(C)OC(CC=1C=CC2=C(N=C(O2)C=2OC=CC2)C1)=O Chemical compound C(C)(C)(C)OC(CC=1C=CC2=C(N=C(O2)C=2OC=CC2)C1)=O WPUNYGUYZBSAKA-UHFFFAOYSA-N 0.000 description 1
- NITXNGVAYYEVBV-UHFFFAOYSA-N CN(C)CCOC(CC=1C=CC2=C(N=C(O2)C2CCCCC2)C1)=O Chemical compound CN(C)CCOC(CC=1C=CC2=C(N=C(O2)C2CCCCC2)C1)=O NITXNGVAYYEVBV-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- AVZIYZHXZAYGJS-UHFFFAOYSA-N Difenidol hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(C=1C=CC=CC=1)(O)CCCN1CCCCC1 AVZIYZHXZAYGJS-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- COFGNCOUABJUCV-UHFFFAOYSA-N N-hydroxy-2-(2-thiophen-3-yl-1,3-benzoxazol-5-yl)acetamide Chemical compound S1C=C(C=C1)C=1OC2=C(N1)C=C(C=C2)CC(=O)NO COFGNCOUABJUCV-UHFFFAOYSA-N 0.000 description 1
- JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229920001938 Vegetable gum Polymers 0.000 description 1
- SMEGJBVQLJJKKX-HOTMZDKISA-N [(2R,3S,4S,5R,6R)-5-acetyloxy-3,4,6-trihydroxyoxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)OC(=O)C)O)O SMEGJBVQLJJKKX-HOTMZDKISA-N 0.000 description 1
- UDVSKCGZPUWRIT-UHFFFAOYSA-M [Na+].C(CCC)C1=CC=C(C=C1)C=1OC2=C(N1)C=C(C=C2)CC(=O)[O-] Chemical compound [Na+].C(CCC)C1=CC=C(C=C1)C=1OC2=C(N1)C=C(C=C2)CC(=O)[O-] UDVSKCGZPUWRIT-UHFFFAOYSA-M 0.000 description 1
- GAMPNQJDUFQVQO-UHFFFAOYSA-N acetic acid;phthalic acid Chemical compound CC(O)=O.OC(=O)C1=CC=CC=C1C(O)=O GAMPNQJDUFQVQO-UHFFFAOYSA-N 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 229940081735 acetylcellulose Drugs 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 125000005001 aminoaryl group Chemical group 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- ZZKLBPLJHJQUJL-UHFFFAOYSA-N benzoic acid;propanoic acid Chemical compound CCC(O)=O.OC(=O)C1=CC=CC=C1 ZZKLBPLJHJQUJL-UHFFFAOYSA-N 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229960004415 codeine phosphate Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 125000004188 dichlorophenyl group Chemical group 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000002389 environmental scanning electron microscopy Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- LVMZRRSPRPGDLD-UHFFFAOYSA-N ethyl 2-[2-(1,3-benzodioxol-5-yl)-1,3-benzoxazol-5-yl]propanoate Chemical compound C1=C2OCOC2=CC(C=2OC3=CC=C(C=C3N=2)C(C)C(=O)OCC)=C1 LVMZRRSPRPGDLD-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940102223 injectable solution Drugs 0.000 description 1
- 229940102213 injectable suspension Drugs 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 238000004452 microanalysis Methods 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- MIQLPFWSTBVVPR-UHFFFAOYSA-N n-(2-hydroxy-4-methylphenyl)benzamide Chemical compound OC1=CC(C)=CC=C1NC(=O)C1=CC=CC=C1 MIQLPFWSTBVVPR-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 1
- 238000006396 nitration reaction Methods 0.000 description 1
- 150000004767 nitrides Chemical group 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 150000004672 propanoic acids Chemical class 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- UENZAQFJJDOROP-UHFFFAOYSA-M sodium;2-[2-(4-bromophenyl)-1,3-benzoxazol-5-yl]propanoate Chemical compound [Na+].N=1C2=CC(C(C([O-])=O)C)=CC=C2OC=1C1=CC=C(Br)C=C1 UENZAQFJJDOROP-UHFFFAOYSA-M 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D263/57—Aryl or substituted aryl radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS763951A CS200456B2 (cs) | 1972-05-18 | 1976-06-15 | Způsob výroby derivátů benzoxazolu |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2340972A GB1435721A (en) | 1972-05-18 | 1972-05-18 | Benzoxazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS200455B2 true CS200455B2 (en) | 1980-09-15 |
Family
ID=10195157
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS733508A CS200455B2 (en) | 1972-05-18 | 1973-05-16 | Method of producing derivatives of benzoxazole |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US3912748A (uk) |
| JP (6) | JPS5912672B2 (uk) |
| KR (1) | KR780000234B1 (uk) |
| AR (4) | AR230991A1 (uk) |
| AT (1) | AT333752B (uk) |
| BE (1) | BE799790A (uk) |
| BG (1) | BG21408A3 (uk) |
| CA (1) | CA1029019A (uk) |
| CH (5) | CH587834A5 (uk) |
| CS (1) | CS200455B2 (uk) |
| CY (1) | CY1016A (uk) |
| DD (1) | DD105229A5 (uk) |
| DE (1) | DE2324443A1 (uk) |
| DK (1) | DK140340B (uk) |
| ES (1) | ES414863A1 (uk) |
| FR (2) | FR2184966B1 (uk) |
| GB (1) | GB1435721A (uk) |
| HK (1) | HK72579A (uk) |
| HU (1) | HU167933B (uk) |
| IE (2) | IE37564B1 (uk) |
| IL (2) | IL42102A (uk) |
| KE (1) | KE2975A (uk) |
| MY (1) | MY8000063A (uk) |
| NL (1) | NL170145C (uk) |
| PH (3) | PH9685A (uk) |
| PL (3) | PL94208B1 (uk) |
| RO (2) | RO66278A (uk) |
| SE (3) | SE386174B (uk) |
| SU (3) | SU574157A3 (uk) |
| YU (3) | YU130473A (uk) |
| ZA (1) | ZA732791B (uk) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3888864A (en) | 1973-06-29 | 1975-06-10 | Hoffmann La Roche | Amino lower alkyl ether derivatives of opium alkaloids |
| GB1495488A (en) * | 1976-06-23 | 1977-12-21 | Ippco Int Pharma Patents Co Es | Optically active 2-(2-phenyl-5-benzoxazolyl)propionic acids |
| US4087437A (en) * | 1976-09-07 | 1978-05-02 | Eli Lilly And Company | 2-Phenyl-5-benzoxazolylalkanoic acid purification process |
| GB1590587A (en) * | 1977-06-28 | 1981-06-03 | Lilly Industries Ltd | Benoxaprofen |
| IT1099589B (it) * | 1978-08-04 | 1985-09-18 | Ravizza Spa | Processo per la preparazione di derivati dell'acido benzoxazolil propionico |
| CA1125768A (en) * | 1978-10-31 | 1982-06-15 | Hoffmann-La Roche Limited | Benzoxazole derivatives |
| GB2058381B (en) | 1979-07-18 | 1983-01-19 | Fuji Photo Film Co Ltd | Colour photographic light-sensitive material containing dye-releasing redox compound |
| GR75153B (uk) * | 1981-03-27 | 1984-07-13 | Lilly Co Eli | |
| IT1157295B (it) * | 1982-07-19 | 1987-02-11 | Ravizza Spa | Processo perfezionato per la preparazione di derivati dell'acido benzoxazolil propionico |
| DE3413875A1 (de) * | 1984-04-12 | 1985-10-17 | Ludwig Heumann & Co GmbH, 8500 Nürnberg | Benzothiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltendes arzneimittel |
| IT1177017B (it) * | 1984-10-22 | 1987-08-26 | Ravizza Spa | Processo per la preparazione dell'acido 2(4-flurofenil)alfa-metil-5-benzox azoloacetico |
| US4873259A (en) * | 1987-06-10 | 1989-10-10 | Abbott Laboratories | Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds |
| US4822809A (en) * | 1987-11-13 | 1989-04-18 | Abbott Laboratories | Benzazole lipoxygenase inhibiting compounds |
| IT1233836B (it) * | 1988-01-13 | 1992-04-21 | Euroresearch Srl | Sali idrosolubili dell'acido (+)2-(4 fluorofenil)-alfa-metil-5 benzoxazolo acetato. |
| UA83620C2 (uk) * | 2001-12-05 | 2008-08-11 | Уайт | Заміщені бензоксазоли та їх аналоги як естрогенні агенти |
| AU2003283597A1 (en) * | 2002-11-16 | 2004-06-15 | Oxford Glycosciences (Uk) Ltd | Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors |
| WO2004076386A2 (en) | 2003-02-25 | 2004-09-10 | Topotarget Uk Limited | Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors |
| AU2005315591B2 (en) * | 2004-12-15 | 2011-03-17 | Dompe' Farmaceutici S.P.A. | 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
| PL1888548T3 (pl) | 2005-05-26 | 2013-01-31 | Neuron Systems Inc | Pochodna chinoliny do leczenia schorzeń siatkówki |
| JP5369854B2 (ja) | 2008-04-21 | 2013-12-18 | 住友化学株式会社 | 有害節足動物防除組成物および縮合複素環化合物 |
| CA2782015C (en) | 2009-12-11 | 2020-08-25 | Neuron Systems, Inc. | Topical ophthalmic compositions and methods for the treatment of macular degeneration |
| KR102435676B1 (ko) | 2013-01-23 | 2022-08-24 | 알데이라 테라퓨틱스, 아이엔씨. | 독성 알데히드 관련된 질병 및 치료 |
| EP2948436A4 (en) | 2013-01-25 | 2016-07-13 | Aldeyra Therapeutics Inc | NOVEL CASES IN THE TREATMENT OF MACULAR GENERATION |
| WO2016021706A1 (ja) * | 2014-08-08 | 2016-02-11 | カズマパートナーズ株式会社 | 縮合複素環化合物 |
| BR112018003250A2 (pt) | 2015-08-21 | 2018-09-25 | Aldeyra Therapeutics Inc | compostos deuterados e usos dos mesmos |
| AU2017264697A1 (en) | 2016-05-09 | 2018-11-22 | Aldeyra Therapeutics, Inc. | Combination treatment of ocular inflammatory disorders and diseases |
| WO2018170476A1 (en) | 2017-03-16 | 2018-09-20 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
| CA3077362A1 (en) | 2017-10-10 | 2019-04-18 | Aldeyra Therapeutics, Inc. | Treatment of inflammatory disorders |
| US12006298B2 (en) | 2018-08-06 | 2024-06-11 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
| JP7505786B2 (ja) | 2018-09-25 | 2024-06-25 | アルデイラ セラピューティクス， インコーポレイテッド | ドライアイ疾患を処置するための製剤 |
| WO2020198064A1 (en) | 2019-03-26 | 2020-10-01 | Aldeyra Therapeutics, Inc. | Ophthalmic formulations and uses thereof |
| US12098132B2 (en) | 2019-05-02 | 2024-09-24 | Aldeyra Therapeutics, Inc. | Process for preparation of aldehyde scavenger and intermediates |
| CA3137301A1 (en) | 2019-05-02 | 2020-11-05 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
| EP4149470A4 (en) | 2020-05-13 | 2024-04-24 | Aldeyra Therapeutics, Inc. | PHARMACEUTICAL FORMULATIONS AND USES THEREOF |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD70860A (uk) * | ||||
| BE625278A (uk) * | 1961-11-27 | |||
| CH516339A (de) * | 1969-03-03 | 1971-12-15 | Ciba Geigy Ag | Verwendung von Azolverbindungen als Antioxydantien |
| DE2118315C3 (de) * | 1970-04-20 | 1975-04-03 | Sumitomo Chemical Co., Ltd., Osaka (Japan) | 2-(1H)-Chinazolinonderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| IL37633A (en) * | 1970-09-10 | 1975-08-31 | Merck & Co Inc | 2-(4-(2-benzoxazolyl)phenyl)alkanoic acid derivatives |
| DE2115926C3 (de) * | 1971-04-01 | 1978-05-03 | C.H. Boehringer Sohn, 6507 Ingelheim | 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel |
| GB1491863A (en) * | 1973-10-23 | 1977-11-16 | Lilly Industries Ltd | 2,5-or 2,6-disubstituted benzoxazoles |
| GB1590587A (en) * | 1977-06-28 | 1981-06-03 | Lilly Industries Ltd | Benoxaprofen |
-
1972
- 1972-05-18 GB GB2340972A patent/GB1435721A/en not_active Expired
-
1973
- 1973-04-25 ZA ZA732791A patent/ZA732791B/xx unknown
- 1973-04-25 IL IL42102A patent/IL42102A/en unknown
- 1973-04-25 IE IE1898/76A patent/IE37564B1/xx unknown
- 1973-04-28 IE IE648/73A patent/IE37563B1/xx unknown
- 1973-05-01 CA CA170,186A patent/CA1029019A/en not_active Expired
- 1973-05-01 US US356251A patent/US3912748A/en not_active Expired - Lifetime
- 1973-05-07 PH PH14592*UA patent/PH9685A/en unknown
- 1973-05-11 AR AR247979A patent/AR230991A1/es active
- 1973-05-15 CY CY1016A patent/CY1016A/xx unknown
- 1973-05-15 DE DE2324443A patent/DE2324443A1/de not_active Ceased
- 1973-05-16 HU HULI244A patent/HU167933B/hu not_active IP Right Cessation
- 1973-05-16 CS CS733508A patent/CS200455B2/cs unknown
- 1973-05-16 KR KR7300790A patent/KR780000234B1/ko active
- 1973-05-16 DD DD170872A patent/DD105229A5/xx unknown
- 1973-05-17 SE SE7307005A patent/SE386174B/xx unknown
- 1973-05-17 AT AT432573A patent/AT333752B/de not_active IP Right Cessation
- 1973-05-17 CH CH1621375A patent/CH587834A5/xx not_active IP Right Cessation
- 1973-05-17 JP JP48055110A patent/JPS5912672B2/ja not_active Expired
- 1973-05-17 SU SU7301916802A patent/SU574157A3/ru active
- 1973-05-17 DK DK274673AA patent/DK140340B/da not_active IP Right Cessation
- 1973-05-17 CH CH1621275A patent/CH595361A5/xx not_active IP Right Cessation
- 1973-05-17 CH CH1298676A patent/CH594643A5/xx not_active IP Right Cessation
- 1973-05-17 YU YU01304/73A patent/YU130473A/xx unknown
- 1973-05-17 ES ES414863A patent/ES414863A1/es not_active Expired
- 1973-05-17 FR FR7317894A patent/FR2184966B1/fr not_active Expired
- 1973-05-17 CH CH703673A patent/CH592071A5/xx not_active IP Right Cessation
- 1973-05-17 CH CH1298576A patent/CH595362A5/xx not_active IP Right Cessation
- 1973-05-18 PL PL1973183011A patent/PL94208B1/pl unknown
- 1973-05-18 PL PL1973182614A patent/PL92565B1/pl unknown
- 1973-05-18 RO RO7374829A patent/RO66278A/ro unknown
- 1973-05-18 RO RO7384621A patent/RO66800A/ro unknown
- 1973-05-18 NL NLAANVRAGE7307018,A patent/NL170145C/xx not_active IP Right Cessation
- 1973-05-18 BG BG023657A patent/BG21408A3/xx unknown
- 1973-05-18 PL PL1973162653A patent/PL89247B1/pl unknown
- 1973-05-18 BE BE6044169A patent/BE799790A/xx not_active IP Right Cessation
-
1974
- 1974-11-21 PH PH16542A patent/PH10704A/en unknown
- 1974-11-21 PH PH16541A patent/PH11718A/en unknown
- 1974-11-29 SU SU7402079273A patent/SU582762A3/ru active
- 1974-11-29 SU SU7402079274A patent/SU580837A3/ru active
-
1975
- 1975-01-01 AR AR257862A patent/AR207857A1/es active
- 1975-01-01 AR AR257863A patent/AR205021A1/es active
- 1975-06-12 FR FR7518361A patent/FR2284592A1/fr active Granted
- 1975-08-22 SE SE7509387A patent/SE434399B/xx not_active IP Right Cessation
- 1975-12-23 IL IL48711A patent/IL48711A0/xx unknown
-
1976
- 1976-03-06 AR AR257861A patent/AR212010A1/es active
-
1977
- 1977-09-21 SE SE7710602A patent/SE435838B/xx not_active IP Right Cessation
-
1979
- 1979-05-17 YU YU1171/79A patent/YU36298B/xx unknown
- 1979-05-17 YU YU01170/79A patent/YU117079A/xx unknown
- 1979-07-03 KE KE2975A patent/KE2975A/xx unknown
- 1979-10-11 HK HK725/79A patent/HK72579A/xx unknown
-
1980
- 1980-12-31 MY MY198063A patent/MY8000063A/xx unknown
-
1981
- 1981-05-13 JP JP7212481A patent/JPS56167675A/ja active Pending
- 1981-05-13 JP JP7212281A patent/JPS56167674A/ja active Pending
- 1981-05-13 JP JP7212181A patent/JPS56167673A/ja active Pending
- 1981-05-13 JP JP56072123A patent/JPS5929185B2/ja not_active Expired
-
1984
- 1984-02-02 JP JP59017637A patent/JPS6021976B2/ja not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS200455B2 (en) | Method of producing derivatives of benzoxazole | |
| CA2219115C (en) | N-benzyl-3-indoleacetic acids as cyclooxygenase-2-inhibitors and antiinflammatory drugs | |
| US4783487A (en) | N-(1-carboxy-2-hydroxy-5-phenyl)-2-(6-methoxy-2-naphthyl)propionamide and anti-inflammatory use thereof | |
| US3810906A (en) | N1-heteroacylated phenylhydrazines | |
| FR2505835A1 (fr) | Nouvelles 1,2-diaminocyclobutene-3,4-diones, leur procede de preparation et composition pharmaceutique les contenant | |
| JPS62501703A (ja) | アミノ−サリチル酸誘導体、その塩、それらの製法およびそれらを含有する医薬組成物 | |
| US4851443A (en) | Carboxylic acid amides, compositions and medical use thereof | |
| JPH11509540A (ja) | アミジン誘導体とシクロオキシゲナーゼ阻害剤との塩、その製造方法、医薬としての応用及びそれを含有する製薬組成物 | |
| RU2194043C2 (ru) | Производные 2-(3h)-оксазолона, способы его получения, фармацевтическая композиция на его основе и способ ингибирования активности сох-2 | |
| US3962452A (en) | Benzoxazole derivatives as therapeutics | |
| US4694018A (en) | Substituted 1,5-diphenyl-2-pyrrolepropionic acids and derivatives | |
| JPS62500872A (ja) | 新規なアゾ化合物 | |
| US3564009A (en) | Process for producing 1-acylindole derivatives | |
| US4011328A (en) | Derivatives of pyridine-3-acetic acid, process for their preparation and applications thereof | |
| JPH0717589B2 (ja) | 新規１，３―ジカルボニル化合物およびその組成物 | |
| JPS5841862A (ja) | 複素環式酢酸化合物および骨疾患の治療用組成物 | |
| UA57031C2 (uk) | Фармацевтична композиція та похідні 4-оксобутанової кислоти | |
| JPH0374668B2 (uk) | ||
| JPH02223548A (ja) | リポキシゲナーゼ抑制化合物およびそれを用いたリポキシゲナーゼの抑制方法 | |
| JPS6044304B2 (ja) | フエニルプロピオン酸誘導体の製造方法 | |
| JPH01228975A (ja) | ベンゾチアジン―１，１―ジオキシド誘導体及びそれを含有する医薬組成物 | |
| JPS5951954B2 (ja) | インド−ル酢酸イソベンゾフラニルエステル、その製造方法及びそれを含有する鎮痛及び抗炎症剤 | |
| JPH0859458A (ja) | インダン誘導体を含有する高脂血症治療剤 | |
| US3891765A (en) | Anti-inflammatory and analgesic L-hydroxyproline derivatives | |
| USRE29608E (en) | Benzoxazole derivatives |